Healthcare Sector
Biogen Share Price: Pipeline Shifts, M&A, and 2026 Outlook
Is the Biogen share price a buy after recent trial misses and the $5.6B Apellis deal? Discover BIIB earnings, pipeline catalysts, and 2026 stock forecasts.
Is UNH Stock a Buy Now? UnitedHealth's 2026 Outlook
Explore whether UNH stock is a buying opportunity in 2026 following UnitedHealth's massive Q1 earnings beat, margin recovery, and restructuring.
Is Roche Stock a Buy? RHHBY Dividends and 2026 Pipeline Forecast
Analyze Roche stock (RHHBY/ROG) in 2026. Discover its 3% dividend yield, Q1 earnings, and emerging obesity, oncology, and digital diagnostics pipelines.
Viatris Stock Analysis: Is the Phase 2 Pivot a Strong Buy?
Viatris stock is escaping its 'value trap' label. Read our deep-dive VTRS stock analysis covering Q1 2026 earnings, dividends, debt payoff, and growth pipeline.
Merck Stock Analysis: Navigating the 2028 Keytruda Patent Cliff
Is Merck stock a buy at its current $122 level? Analyze Q1 2026 earnings, dividend safety, and how the massive $70B pipeline plans to offset the Keytruda cliff.
Cigna Stock Analysis: Is NYSE:CI a Buy at 9x Earnings?
Analyze Cigna stock performance, Q1 2026 earnings, PBM regulations, and analyst outlooks. Is this cheap healthcare giant a buy, hold, or sell?